The relationship of cancer characteristics and patient outcome with time to lung cancer diagnosis after an abnormal screening CT

European Radiology

Volumn 27, Issue 12, 2017, Pages 5113-5118

  Sonavane, Sushilkumar K ^a   Pinsky, Paul ^b   Watts, Jubal ^a   Gierada, David S ^c   Munden, Reginald ^d   Singh, Satinder P ^a   Nath, Hrudaya ^a  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Computed tomography; Diagnosis; Lung cancer; Mortality; Screening

Indexed keywords

ADULT; AGED; ALL CAUSE MORTALITY; ARTICLE; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR VOLUME; X-RAY COMPUTED TOMOGRAPHY; ADENOCARCINOMA; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; LUNG TUMOR; MASS SCREENING; MIDDLE AGED; MORTALITY; PATHOLOGY; PROCEDURES; STATISTICAL MODEL;

ADENOCARCINOMA; AGED; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85020740024     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-017-4886-9     Document Type: Article

References (26)

1. American Cancer Society (2014) Cancer facts & figures, 2014. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures 2014.html. Accessed 22 Mar 2017
2. NIH (2017) National Cancer Institute: Surveillance, Epidemiology, and End Results (SEER) Program Cancer statistics review, 2006–2012. https://seer.cancer.gov/statfacts/html/lungb.html. Accessed 22 Mar 2017
3. National Lung Screening Trial Research Team, Aberle DR, Adams AM et al (2011) Reduced lung cancer mortality with low-dose computed tomographic screening. N Engl J Med 365:395–409
4. Aberle DR, DeMello S, Berg CD et al (2013) Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med 369:920–931
5. National Lung Screening Trial Research Team, Aberle DR, Berg CD et al (2011) The National Lung Screening Trial: overview and study design. Radiology 258:243–253
6. Olsson JK, Schultz EM, Gould MK (2009) Timeliness of care in patients with lung cancer: a systematic review. Thorax 64:749–756
7. Koyi H, Hillerdal G, Brandén E (2002) Patient’s and doctors’ delays in the diagnosis of chest tumors. Lung Cancer 35:53–57
8. Porta M, Gallén M, Malats N, Planas J (1991) Influence of ‘diagnostic delay’ upon cancer survival: an analysis of five tumour sites. J Epidemiol Community Health 45:225–230
9. Pita-Fernández S, Montero-Martinez C, Pértega-Diaz S, Verea-Hernando H (2003) Relationship between delayed diagnosis and the degree of invasion and survival in lung cancer. J Clin Epidemiol 56:820–825
10. Salomaa ER, Sällinen S, Hiekkanen H, Liippo K (2005) Delays in the diagnosis and treatment of lung cancer. Chest 128:2282–2288
11. Kanashiki M, Satoh H, Ishikawa H, Yamashita YT, Ohtsuka M, Sekizawa K (2003) Time from finding abnormality on mass screening to final diagnosis of lung cancer. Oncol Rep 10:649–652
12. Kashiwabara K, Koshi S, Itonaga K, Nakahara O, Tanaka M, Toyonaga M (2003) Outcome in patients with lung cancer found on lung cancer mass screening roentgenograms, but who did not subsequently consult a doctor. Lung Cancer 40:67–72
13. Tørring ML, Frydenberg M, Hansen RP, Olesen F, Vedsted P (2013) Evidence of increasing mortality with longer diagnostic intervals for five common cancers: a cohort study in primary care. Eur J Cancer 49:2187–2198
14. Myrdal G, Lambe M, Hillerdal G, Lamberg K, Agustsson T, Ståhle E (2004) Effect of delays on prognosis in patients with non-small cell lung cancer. Thorax 59:45–49
15. Comber H, Cronin DP, Deady S, Lorcain PO, Riordan P (2005) Delays in treatment in the cancer services: impact on cancer stage and survival. Ir Med J 98:238–299
16. Annakkaya AN, Arbak P, Balbay O, Bilgin C, Erbas M, Bulut I (2007) Effect of symptom-to-treatment interval on prognosis in lung cancer. Tumori 93:61–67
17. Kodama K, Higashiyama M, Yokouchi H et al (2001) Prognostic value of ground-glass opacity found in small lung adenocarcinoma on high-resolution CT scanning. Lung Cancer 33:17–25
18. ELCAP Group, Henschke CI, Yankelevitz DF, Mirtcheva R, McGuinness G, McCauley D, Miettinen OS (2002) CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR Am J Roentgenol 178:1053–1057
19. Vazquez M, Carter D, Brambilla E et al (2009) Solitary and multiple resected adenocarcinomas after CT screening for lung cancer: histopathologic features and their prognostic implications. Lung Cancer 64:148–154
20. Heyneman LE, Patz EF (2002) PET imaging in patients with bronchioloalveolar cell carcinoma. Lung Cancer 38:261–266
21. Wu HB, Wang L, Wang QS et al (2015) Adenocarcinoma with BAC features presented as the nonsolid nodule is prone to be false-negative on 18 F-FDGPET/CT. Biomed Res Int 2015:243681
22. Chang B, Hwang JH, Choi YH et al (2013) Natural history of pure ground glass opacity lung nodules detected by low-dose CT scan. Chest 143:172–178
23. Yip R, Yankelevitz DF, Hu M et al (2016) Lung cancer deaths in the National Lung Screening Trial attributed to nonsolid nodules. Radiology 281:589–596
24. MacMahon H, Naidich DP, Goo JM et al (2017) Guidelines for management of incidental pulmonary nodules detected on CT images: from the Fleischner Society 2017. Radiology. doi:10.1148/radiol.2017161659
25. Guideline Development Group, Baldwin DR, Callister ME (2015) The British Thoracic Society guidelines on the investigation and management of pulmonary nodules. Thorax 70:794–798
26. Lung-RADS™ Version 1.0 Assessment Categories. Release date April 28, 2014